NIH-funded research R01 grant

Investigating how HIV-1 persists in immune cells

Official title: Understanding HIV-1 persistence in cytotoxic CD4+ T lymphocytes at the single cell level

Funded at Yale University · NIH-11074636 · Data updated 2026-11-12

This study is looking at how HIV-1 stays in the body even when people are on effective treatment, and it’s for individuals living with HIV-1 to help find new ways to improve their care by understanding the immune cells involved.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionYale University
NIH-funded
Lab location1 site (New Haven, United States)
Project startMay 11, 2023
Project endApril 30, 2027
Funding year2025
Award (this year)$840,074
NIH project number5R01AI174863-03
Project IDNIH-11074636 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals living with HIV-1 who are currently on antiretroviral therapy and have achieved viral suppression.

Less likely to help

Patients who are not living with HIV-1 or those who are not on antiretroviral therapy may not benefit from this research.

What this research studies

This research focuses on understanding how HIV-1 survives and persists in the body despite effective antiretroviral therapy (ART). By examining CD4+ T cells from individuals living with HIV-1, the study aims to identify the immune cell subsets and markers associated with HIV-1 infection. Using advanced techniques like single-cell ECCITEseq, researchers will analyze the characteristics of these cells at a detailed level, which may reveal new therapeutic targets for treatment. The goal is to better understand the mechanisms of HIV-1 persistence to improve patient outcomes.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for eliminating HIV-1 from the body and improving treatment for patients living with the virus.

How similar studies have gone: Other research has shown promise in understanding HIV-1 persistence using similar advanced single-cell analysis techniques, indicating a potential for success in this approach.

Where this research is happening

  • Yale University
    New Haven, United States
    Active

Researchers

  • Principal investigator: Ho, Ya-Chi — Yale University
  • Study coordinator: Ho, Ya-Chi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.